Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma

Jurriaan B. Tuynman, Christianne J. Buskens, Kristel Kemper, Fiebo J W Ten Kate, G. Johan A Offerhaus, Dirk J. Richel, J. Jan B Van Lanschot, [No Value] Lerut, [No Value] Eggermont, [No Value] Lundell

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science